| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e10d51bb2cf4da8c6fcca221d86ef180
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a1cd7029ec038fa78d4b371f9bf08e9e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6ed894ddd5807b6d95721599fcd94e4d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_21b91c6c5872509d9722429dbc8e84ee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a5b0eac1d82b85704154b4865d679437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ba41258c4953660dedb8694577355158 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-112
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57484
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57415 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2003-03-20^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_734f379bdc58827ccfd8b0e26818d89b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5d9a4b6af0bc729c92f86cd6e0cea9c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_640f79b0802bf38cc895df0868476423
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_382838747329197eb4620cce5a41855d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_009c9f869a79255db0c48206fdc2b289 |
| publicationDate |
2003-10-30^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-03089924-A1 |
| titleOfInvention |
Determining cancer aggressiveness |
| abstract |
The invention provides materials and methods for determining the aggressiveness of a cancer in a mammal. Specifically, the invention provides methods and methods for measuring the level of a TIEG marker in a sample. Such levels can be correlated with the aggressiveness of a cancer to predict patient outcome and develop treatment regimens. |
| priorityDate |
2002-04-15^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |